Dacryocystitis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Dacryocystitis Treatment Market is anticipated to register at a CAGR of nearly 4% during the forecast period 2022-2028.

Dacryocystitis refers to inflammation of the lacrimal glands (tear sacs). It is caused by obstruction within the nasolacrimal duct and consequent stagnation of the lacrimal sac. These infections can be acute or chronic. Its symptoms include pain, redness, and swelling in the lower eyelid and the inner part of the eyelid. These infections usually occur in infants and adults over the age of 40. Treatment choices depend on indications such as oral antibiotics, systemic antibiotics (in most cases complex), and surgery for recurrent infections, depending on the signs of dacryocystitis.

Market Segments

Based on indication

• Acute
• Chronic
• Acquired
• Congenital

Based on treatment type

• Crigler Massages
• Oral Antibiotics
• Systemic Antibiotics
• Surgery
  • Balloon Dacryoplasty
  • Nasolacrimal Intubation
  • Nasolacrimal Stents
  • Percutaneous Dacryocystorhinostomy Tubes
  • Endonasal Dacryocystorhinostomy Tubes

Key Players

•  Pfizer
•  Abbott Laboratories
•  Glaxosmithkline
•  Mylan
•  Cipla
•  FCI Ophthalmics
•  Aurolab
•  Kaneka
•  Gunther Weiss Scientific Glass
•  Bess Medizintechnik GmbH

Scope of the Report

The research study analyzes the global Dacryocystitis Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Dacryocystitis Treatment Market Report

1. What was the Dacryocystitis Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Dacryocystitis Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Dacryocystitis Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.